Biblio

Found 56 results
Author Keyword [ Title(Desc)] Type Year
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ridge PG, Mukherjee S, Crane PK, Kauwe JSK.  2013.  Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.
Karch CM, Cruchaga C, Goate AM.  2014.  Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.
Thambisetty M, An Y, Tanaka T.  2013.  Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R.  2008.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.. Arch Neurol. 65(11):1518-26.
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al..  2004.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
Reynolds CA, Hong M-G, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Grönberg H et al..  2010.  Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.. Hum Mol Genet. 19(10):2068-78.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al..  2010.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.
C
Sonnega A, Faul JD, Ofstedal MBeth, Langa KM, Phillips JWR, Weir DR.  2014.  Cohort Profile: the Health and Retirement Study (HRS).. Int J Epidemiol. 43(2):576-85.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JSingh, Moskvina V et al..  2011.  Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.
Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA et al..  2004.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.
Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, Griffith P, Obisesan TO, Shatz R, Borenstein A et al..  2011.  A comprehensive genetic association study of Alzheimer disease in African Americans.. Arch Neurol. 68(12):1569-79.
Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH.  2005.  Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder.. Am J Med Genet B Neuropsychiatr Genet. 139B(1):51-3.